OPEN LETTER – We stay open for you and your patients – Please read

15. March 2020

We stay open for you and your patients! We used the last days to prepare us to continue our...

Read more

Diagnostic Strategy for Females Suspected of Fabry Disease

18. February 2020

Fabry disease, an X-linked inherited lysosomal storage disorder, can be overlooked in heterozygous females due to random X-inactivation. In...

Read more

amedes and ARCHIMEDlife – a new strong international alliance

17. January 2020

ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and...

Read more

ARCHIMEDlife and Blueprint Genetics – partnership in North America

25. September 2019

Combining high-quality biochemical testing with innovative genetic testing forms a powerful tool for personalized medicine, clinical research and diagnostics...

Read more

SSIEM 2019 in Rotterdam

27. August 2019

Exciting! Our booth with a brand new look and novel, innovative portfolio of diagnostic tests and services. First time...

Read more

New cut-offs for lysosomal enzyme activities.

6. June 2019

We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal...

Read more

Become part of our readers´ community

12. November 2017

You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...

Read more

Newborn Screening Awareness Month: Expanded Newborn Screening for dozens of metabolic diseases

1. September 2017

September is Newborn Screening Awareness Month. Not only throughout this time we like to remind you, that you can...

Read more

Now published: A consensus guideline for newborn screening by mass spectrometry

25. July 2017

An updated Consensus Guideline by worldwide experts is now available: See the publication of CLSI document NBS04-Ed2, Newborn Screening...

Read more

Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease

5. July 2017

Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA)...

Read more